Clinical Trials Browser

Expanded_access × Anus Neoplasms × Gastrointestinal × Clear all

NCT06910137 2026-01-08

An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)

Gastrointestinal

Anus Neoplasms, Carcinoma, Squamous Cell